OMER vs HPAI Comparison

Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The drug candidate in the pipeline of complement-targeted therapeutics is narsoplimab (OMS721), a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is currently focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin nephropathy.

Helport AI Ltd is an artificial intelligence (AI) technology company that provides software-as-a-service and AI tools to the contact center industry. The flagship product, AI Assist, is a real-time, intelligent software co-pilot for customer engagement professionals. Its AI + Business Process Outsourcing (BPO) service combines AI software with customer contact agents as a turnkey offering for enterprise customers. The company is headquartered in Singapore, with operations across Asia and North America. It provides solutions to the public sector, including insurance, wealth management, mortgage, and others.